Autoimmunity Centers of Excellence

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy	autoimmune disease, immune system disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease	Recruiting	Phase 2	2026-09-17		NCT07103746
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis	CNS demyelinating autoimmune disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder	Active, not recruiting	Phase 4	2026-09-01		NCT05285891

Clinical trials